Markers for endothelial activation during open heart surgery

被引:26
作者
Eikemo, H
Sellevold, AFM
Videm, V
机构
[1] Univ Trondheim Hosp, St Elisabeth Heart Ctr, Dept Immunol & Transfus Med, Trondheim, Norway
[2] Univ Trondheim Hosp, St Elisabeth Heart Ctr, Dept Anesthesia & Intens Care, Trondheim, Norway
[3] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
关键词
D O I
10.1016/S0003-4975(03)01060-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Reliable markers for endothelial activation are needed when studying biocompatibility of cardiopulmonary bypass. Methods. Blood samples from 21 patients undergoing combined valve and coronary artery bypass surgery were collected before anesthesia (T1), after re-transfusion of blood from the heart-lung. machine (T2), and on the first postoperative morning M). Concentrations of soluble markers were determined using sandwich enzyme-linked immunoadsorbent assay for sICAM-1, sVCAM-1, and sE-selectin. The sera were also used to stimulate human umbilical vein endothelial cells (HUVEC) in culture for 6 hours, in which activation was measured using cell enzyme immunoassay for mICAM-1 and mVCAM-1. Results. The concentrations of sICAM-1 and sVCAM-1 increased during both measurement intervals (p<0.05). The sICAM-1 T1 was 311.0 ng/mL (range, 271.0 to 350.7 ng/mL); the sICAM-1 T2 was 341.6 ng/mL (range, 322.0 to 422.0 ng/mL), and the sICAM-1 T3 was 400.2 ng/mL (range, 348.0 to 556.4 ng/mL; the sVCAM-1 T1 was 607.5 ng/mL (range, 497.8 to 813.8 ng/mL), the sVCAM-1 T2 was 755.3 ng/mL (range, 660.6 to 834.4 ng/mL), and the sVCAM-1 T3 was 1149.0 ng/mL (946.0 to 1406.0 ng/mL); whereas the sE-selectin increased from T1 to T3 (p<0.01). Both the mICAM-1 (p<0.002) and the mVCAM-1 (p<0.005) increased on the human umbilical vein endothelial cells in culture after stimulation with the patient sera. The amounts of soluble markers in vivo were not correlated with the degree of endothelial activation in vitro, but were correlated with various operative variables including age, medication, and time of aortic cross-clamping. Conclusions. Endothelial cells were activated during cardiopulmonary bypass. The soluble adhesion molecules sICAM-1, sVCAM-1, and sE-selectin displayed different kinetics, rendering it difficult to determine a simple expression for the degree of endothelial cell activation. Clinically, sVCAM-1 seemed to be the best-suited marker for endothelial cell activation, because it was only associated with aortic cross-clamping and heparin and protamine doses, and it also showed the largest numerical changes.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 28 条
[1]   Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass [J].
Andresen, TK ;
Svennevig, JL ;
Videm, V .
PERFUSION-UK, 2002, 17 (01) :15-21
[2]  
Blume ED, 1997, CIRCULATION, V96, P352
[3]   Hypothermic versus normothermic cardiopulmonary bypass: Influence on circulating adhesion molecules [J].
Boldt, J ;
Osmer, C ;
Linke, LC ;
Gorlach, G ;
Hempelmann, G .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (03) :342-347
[4]   RETRACTED: Does age influence circulating adhesion molecules in the critically ill? (Retracted Article) [J].
Boldt, J ;
Muller, M ;
Heesen, M ;
Papsdorf, M ;
Hempelmann, G .
CRITICAL CARE MEDICINE, 1997, 25 (01) :95-100
[5]   RETRACTED: Are circulating adhesion molecules specifically changed in cardiac surgical patients? (Retracted article. See vol. 111, 2021) [J].
Boldt, J ;
Kumle, B ;
Papsdorf, M ;
Hempelmann, G .
ANNALS OF THORACIC SURGERY, 1998, 65 (03) :608-614
[6]  
CONOVER WJ, 2002, PRACTICAL NONPARAMET, P367
[7]  
FRIES JWU, 1993, AM J PATHOL, V143, P725
[8]   Heterogeneity of endothelial cells - Specific markers [J].
Garlanda, C ;
Dejana, E .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) :1193-1202
[9]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[10]   Selectins and their ligands: Current concepts and controversies [J].
Kansas, GS .
BLOOD, 1996, 88 (09) :3259-3287